This report provides a comprehensive analysis of the global enterprise imaging IT market, which is poised for significant growth driven by the transition toward cloud-native SaaS deployments and AI-integrated diagnostic workflows. The study examines key segments including diagnostics and cardiology, while highlighting technological advancements like blockchain-backed provenance and quantitative radiomics. Regionally, the Asia Pacific market is expected to experience the fastest expansion due to digital health initiatives and medical tourism. Furthermore, the report evaluates the competitive landscape and strategic maneuvers of major industry players.

Market Overview

The global enterprise imaging IT market is projected to grow from USD 2.31 billion in 2025 to USD 4.12 billion by 2030, representing a CAGR of 12.2% during the forecast period.

Key Market Drivers and Trends

• Shift in Deployment Models: Demand is propelled by the transition from capital-heavy license models to cloud-native SaaS deployments, which lower upfront costs and accelerate upgrades.
• Data Integrity and Auditability: The emergence of blockchain-backed image provenance platforms is enhancing data integrity and auditability across multi-vendor ecosystems.
• Medical Tourism: Growing medical tourism networks are driving the need for standardized, cross-border image exchange hubs.
• Workflow Expansion: The proliferation of point-of-care ultrasound and wearable imaging devices is expanding enterprise workflows to include real-time, bedside acquisitions.

Market Segmentation

By Application

• Diagnostics: This is the fastest-growing segment and accounts for the largest share of the enterprise imaging IT market. Growth is driven by:
• The nationwide rollout of lung cancer screening programs, increasing low-dose CT volumes and enterprise archive demand.
• The integration of AI-driven triage engines for automatically flagging critical findings (e.g., intracranial hemorrhages or pulmonary emboli).
• The rise of quantitative radiomics and texture analysis workflows for oncology and neurology imaging, creating demand for high-dimensional feature set processing.
• Therapeutics
• Clinical Research

By Therapeutic Area

• Cardiology: Estimated to hold the largest share of the enterprise imaging IT market in 2024. Drivers include:
• The surge in CT-derived fractional flow reserve (FFR CT) workflows requiring seamless integration of computational models and high-fidelity CT archives.
• The expansion of hybrid cath lab/OR suites driving demand for enterprise viewers capable of real-time 3D vessel reconstruction overlays during transcatheter valve and structural interventions.
• New CPT codes for AI-quantified ejection fraction and chamber volumetrics.
• The proliferation of wearable ECG and implantable device data streams necessitating the fusion of multi-source signals with imaging studies.
• Neurology
• Oncology
• Orthopedics
• Other Therapeutic Areas

By Region

• Asia Pacific: Expected to register the highest growth rate during the forecast period. Key regional factors include:
• India’s National Digital Health Mission integrating imaging data into its Health Locker for unified patient records.
• The rise of medical tourism hubs in Malaysia and Thailand requiring seamless cross-border image exchange.
• Public–private partnerships deploying mobile CT and MRI units in rural China.
• The explosive uptake of low-cost, AI-powered handheld ultrasound devices in South Korea and India.
• North America
• Europe
• Latin America
• Middle East & Africa

Participant Breakdown

By Company Type

• Tier 1: 41%
• Tier 2: 31%
• Tier 3: 28%

By Designation

• C-level Executives: 44%
• Directors: 31%
• Others: 25%

By Region

• North America: 45%
• Europe: 28%
• Asia Pacific: 20%
• Latin America: 4%
• Middle East & Africa: 3%

Competitive Landscape

Key Players

• Agfa-Gevaert Group (Belgium)
• FUJIFILM Corporation (Japan)
• Merative (US)
• Pro Medicus, Ltd. (Australia)
• Optum, Inc. (US)
• GE HealthCare (US)
• Intelerad (Canada)
• Sectra AB (Sweden)
• CANON MEDICAL SYSTEMS CORPORATION (Japan)
• Hyland Software, Inc. (US)
• Koninklijke Philips N.V. (Netherlands)
• Siemens Healthineers AG (Germany)
• INFINITT Healthcare Co., Ltd. (South Korea)
• Novarad (US)
• Mach7 Technologies (US)
• Hermes Medical Solutions (Sweden)
• Konica Minolta, Inc. (Japan)
• BridgeHead Software Ltd. (England)
• Sclmage, Inc. (US)
• VISUS Health IT GmbH (Germany)
• Dicom Systems, Inc. (US)
• PostDICOM (Netherlands)
• Qaelum (Belgium)
• AdvaHealth Solutions (Singapore)
• PaxeraHealth (US)
• Rad AI (US)

Growth Strategies

Players utilize organic and inorganic growth strategies, including:

• Solution launches, enhancements, and upgrades
• Collaborations and partnerships
• Acquisitions
• Agreements and expansions

Research Coverage

• Market Dimensions: Studies based on function, modality, application, offering, deployment mode, therapeutic area, end user, and region.
• Market Dynamics: Analysis of drivers, restraints, opportunities, and challenges.
• Stakeholder Analysis: Evaluation of market opportunities, challenges, and the competitive landscape for market leaders.
• Micromarket Analysis: Study of growth trends, prospects, and contributions of micromarkets to the total market.
• Revenue Forecasting: Forecasts of market segment revenue across five major regions.

Value Proposition: Reasons to Buy the Report

This report assists both established firms and new entrants/smaller firms in gauging market trends to capture greater market share. Key insights provided include:

• Growth Drivers & Challenges: Analysis of key factors influencing market growth.
• Product Development/Innovation: Detailed insights into upcoming technologies, R&D activities, and product launches.
• Market Development: Comprehensive information on lucrative emerging markets and various solution types across regions.
• Market Diversification: Information regarding products, untapped regions, recent developments, and investments.
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players.

• 1 INTRODUCTION 33

  • 1.1 STUDY OBJECTIVES 33

  • 1.2 MARKET DEFINITION 33

  • 1.3 MARKET SCOPE 34

    • 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 34

    • 1.3.2 INCLUSIONS & EXCLUSIONS 35

  • 1.4 YEARS CONSIDERED 36

  • 1.5 CURRENCY 37

  • 1.6 LIMITATIONS 37

  • 1.7 STAKEHOLDERS 38

• 2 RESEARCH METHODOLOGY 39

  • 2.1 RESEARCH DATA 39

    • 2.1.1 SECONDARY DATA 40

      • 2.1.1.1 Key data from secondary sources 40

    • 2.1.2 PRIMARY DATA 41

      • 2.1.2.1 Key data from primary sources 42
      • 2.1.2.2 Breakdown of primary sources 43

  • 2.2 RESEARCH APPROACH 44

  • 2.3 MARKET SIZE ESTIMATION 45

  • 2.4 MARKET BREAKDOWN & DATA TRIANGULATION 52

  • 2.5 RESEARCH ASSUMPTIONS 53

    • 2.5.1 MARKET SIZING ASSUMPTIONS 53

    • 2.5.2 OVERALL STUDY ASSUMPTIONS 53

  • 2.6 RISK ASSESSMENT 54

  • 2.7 RESEARCH LIMITATIONS 54

    • 2.7.1 METHODOLOGY-RELATED LIMITATIONS 54

    • 2.7.2 SCOPE-RELATED LIMITATIONS 54

• 3 EXECUTIVE SUMMARY 55

• 4 PREMIUM INSIGHTS 60

  • 4.1 ENTERPRISE IMAGING IT MARKET OVERVIEW 60

  • 4.2 NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY APPLICATION & REGION 61

  • 4.3 ENTERPRISE IMAGING IT MARKET: GEOGRAPHIC SNAPSHOT 62

  • 4.4 ENTERPRISE IMAGING IT MARKET: DEVELOPED VS. EMERGING ECONOMIES 63

• 5 MARKET OVERVIEW 64

  • 5.1 INTRODUCTION 64

  • 5.2 MARKET DYNAMICS 64

    • 5.2.1 DRIVERS 66

      • 5.2.1.1 Increased demand for scalable and cost-effective solutions 66
      • 5.2.1.2 Advancements in Al and imaging technologies 66
      • 5.2.1.3 Growing volume of medical imaging procedures 67
      • 5.2.1.4 Growing need for remote access and collaborative care 67
      • 5.2.1.5 Government initiatives and favorable policies 68

    • 5.2.2 RESTRAINTS 69

      • 5.2.2.1 Data security and privacy concerns 69
      • 5.2.2.2 Lack of skilled professionals for deployment and interpretation 72

    • 5.2.3 OPPORTUNITIES 73

      • 5.2.3.1 Expansion into emerging markets 73
      • 5.2.3.2 Multi modality and advanced visualization 74
      • 5.2.3.3 Partnerships with AI and analytics providers 74
      • 5.2.3.4 Value-based care and population health management 75
      • 5.2.3.5 Cloud native and edge computing innovations 76

    • 5.2.4 CHALLENGES 76

      • 5.2.4.1 Interoperability with legacy and vendor-specific systems 76
      • 5.2.4.2 High upfront integration and deployment costs 76
      • 5.2.4.3 Workflow disruption and user adoption 77

  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 77

  • 5.4 INDUSTRY TRENDS 78

    • 5.4.1 AI-ENABLED DIAGNOSTICS AND PREDICTIVE ANALYTICS 78

    • 5.4.2 UNIFIED IMAGING DATA INTEGRATION AND COLLABORATIVE DIAGNOSTICS 79

    • 5.4.3 CLOUD-BASED IMAGING IT PLATFORMS AND DIGITAL TRANSFORMATION 79

  • 5.5 ECOSYSTEM ANALYSIS 80

  • 5.6 SUPPLY CHAIN ANALYSIS 83

  • 5.7 TECHNOLOGY ANALYSIS 85

    • 5.7.1 KEY TECHNOLOGIES 85

      • 5.7.1.1 Imaging analytics platforms 86
      • 5.7.1.2 Artificial intelligence and machine learning 86
      • 5.7.1.3 Multi modality fusion & co registration engines 87
      • 5.7.1.4 Zero footprint viewers 87
      • 5.7.1.5 Mobile enterprise imaging and workflow bots 87

    • 5.7.2 COMPLEMENTARY TECHNOLOGIES 88

      • 5.7.2.1 Radiology information systems (RIS) 88
      • 5.7.2.2 Electronic health record (EHR/EMR) integration 88

    • 5.7.3 ADJACENT TECHNOLOGIES 89

      • 5.7.3.1 Cloud computing & storage 89
      • 5.7.3.2 Blockchain & distributed ledger technology 89

  • 5.8 REGULATORY ANALYSIS 90

    • 5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, & OTHER ORGANIZATIONS 90

    • 5.8.2 REGULATORY LANDSCAPE 94

      • 5.8.2.1 North America 94
      • 5.8.2.2 Europe 95
      • 5.8.2.3 Asia Pacific 96
      • 5.8.2.4 Latin America 97
      • 5.8.2.5 Middle East & Africa 97

  • 5.9 PRICING ANALYSIS 98

    • 5.9.1 INDICATIVE PRICING FOR ENTERPRISE IT IMAGING SOLUTIONS, BY FUNCTION (2024) 99

    • 5.9.2 INDICATIVE PRICING FOR ENTERPRISE IT IMAGING SOLUTIONS, BY REGION (2024) 99

  • 5.10 PORTER’S FIVE FORCES ANALYSIS 100

    • 5.10.1 BARGAINING POWER OF SUPPLIERS 102

    • 5.10.2 BARGAINING POWER OF BUYERS 102

    • 5.10.3 THREAT OF SUBSTITUTES 102

    • 5.10.4 THREAT OF NEW ENTRANTS 102

    • 5.10.5 INTENSITY OF COMPETITIVE RIVALRY 102

  • 5.11 PATENT ANALYSIS 103

    • 5.11.1 PATENT PUBLICATION TRENDS FOR ENTERPRISE IMAGING IT MARKET 103

    • 5.11.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 104

  • 5.12 KEY STAKEHOLDERS & BUYING CRITERIA 107

    • 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 107

    • 5.12.2 BUYING CRITERIA 108

  • 5.13 END-USER ANALYSIS 109

    • 5.13.1 UNMET NEEDS 109

    • 5.13.2 END-USER EXPECTATIONS 110

  • 5.14 KEY CONFERENCES & EVENTS, 2025-2026 111

  • 5.15 CASE STUDY ANALYSIS 112

  • 5.16 INVESTMENT & FUNDING SCENARIO 114

  • 5.17 BUSINESS MODEL ANALYSIS 115

  • 5.18 IMPACT OF GENERATIVE AI ON ENTERPRISE IMAGING IT MARKET 116

    • 5.18.1 TOP USE CASES & MARKET POTENTIAL 116

      • 5.18.1.1 Key use cases 117

    • 5.18.2 CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION 118

      • 5.18.2.1 Case Study 1: Enabling interoperability and scalability across enterprise imaging networks with Dicom Systems’ Unifier Platform 118
      • 5.18.2.2 Case Study 2: More images, more insight, more collaboration - San Gerardo Hospital transforms radiology with Agfa HealthCare’s Enterprise Imaging 119

    • 5.18.3 INTERCONNECTED & ADJACENT MARKETS 120

      • 5.18.3.1 Vendor Neutral Archive (VNA) & PACS Market 120
      • 5.18.3.2 Medical Image Analysis Software Market 120
      • 5.18.3.3 Healthcare IT Market 121

    • 5.18.4 USER READINESS & IMPACT ASSESSMENT 121

      • 5.18.4.1 User readiness 121
        • 5.18.4.1.1 User A: Hospitals 121
        • 5.18.4.1.2 User B: Diagnostic centers 121
      • 5.18.4.2 Impact assessment 122
        • 5.18.4.2.1 User A: Hospitals 122
          • 5.18.4.2.1.1 Implementation 122
          • 5.18.4.2.1.2 Impact 122
        • 5.18.4.2.2 User B: Diagnostic centers 122
          • 5.18.4.2.2.1 Implementation 122
          • 5.18.4.2.2.2 Impact 123

  • 5.19 IMPACT OF 2025 US TARIFFS ON ENTERPRISE IMAGING IT MARKET 123

    • 5.19.1 INTRODUCTION 123

    • 5.19.2 KEY TARIFF RATES 124

    • 5.19.3 PRICE IMPACT ANALYSIS 124

      • 5.19.3.1 Increased costs of hardware components 125
      • 5.19.3.2 Software & licensing inflation 125
      • 5.19.3.3 Supply chain disruption 125

    • 5.19.4 IMPACT ON COUNTRY/REGION 125

      • 5.19.4.1 US 125
      • 5.19.4.2 Europe 125
      • 5.19.4.3 Asia Pacific 126

    • 5.19.5 IMPACT ON END USERS 126

      • 5.19.5.1 Hospitals (large, mid-sized, and academic medical centers) 126
      • 5.19.5.2 Diagnostic centers (independent and chain-based) 126
      • 5.19.5.3 Teleradiology providers 126

• 6 ENTERPRISE IMAGING IT MARKET, BY FUNCTION 128

  • 6.1 INTRODUCTION 129

  • 6.2 VENDOR NEUTRAL ARCHIVES (VNA) 129

    • 6.2.1 ADVANCING SEAMLESS INFORMATION EXCHANGE THROUGH VNA SOLUTIONS TO BOOST MARKET GROWTH 129

  • 6.3 PICTURE ARCHIVING AND COMMUNICATION SYSTEMS (PACS) 131

    • 6.3.1 GROWING INTEGRATION OF AI WITHIN PACS FOR OPTIMIZED RADOIOLOGY WORKFLOWS TO SUPPORT MARKET GROWTH 131

  • 6.4 IMAGE EXCHANGE 132

    • 6.4.1 GROWING POPULARITY OF INTEROPERABLE IMAGING NETWORKS FOR PATIENT-CENTERED DATA SHARING TO DRIVE GROWTH 132

  • 6.5 UNIVERSAL VIEWERS 134

    • 6.5.1 GROWING UNIVERSAL VIEWER DEPLOYMENT FOR MULTI-DISCIPLINARY IMAGING TO FUEL MARKET 134

  • 6.6 WORKFLOW ORCHESTRATION 135

    • 6.6.1 AI-POWERED IMAGING WORKFLOW AUTOMATION AND CROSS-MODALITY COORDINATION TO PROPEL MARKET 135

  • 6.7 ANALYTICS 137

    • 6.7.1 GROWING NEED FOR ANALYTICS PLATFORMS FOR VALUE-BASED IMAGING AND OPERATIONAL OPTIMIZATION TO DRIVE MARKET 137

  • 6.8 OTHER FUNCTIONS 138

• 7 ENTERPRISE IMAGING IT MARKET, BY APPLICATION 140

  • 7.1 INTRODUCTION 141

  • 7.2 DIAGNOSTICS 141

    • 7.2.1 AI-ENABLED QUANTIFICATION AND INTEGRATED THERANOSTIC WORKFLOWS TO DRIVE DIAGNOSTIC IMAGING TRANSFORMATION 141

  • 7.3 THERAPEUTICS 142

    • 7.3.1 ADVANTAGES SUCH AS MULTIMODAL TREATMENT INTEGRATION TO OPTIMIZE ENTERPRISE IMAGING FOR THERAPEUTIC WORKFLOWS 142

  • 7.4 CLINICAL RESEARCH 143

    • 7.4.1 AI-ENABLED QUANTIFICATION AND RAPID-RESPONSE IMAGING WORKFLOWS TO ACCELERATE CLINICAL RESEARCH 143

• 8 ENTERPRISE IMAGING IT MARKET, BY MODALITY 145

  • 8.1 INTRODUCTION 146

  • 8.2 X-RAY 146

    • 8.2.1 GROWTH IN ENTERPRISE IMAGING THROUGH AI-ENABLED X-RAY SOLUTIONS TO BOOST MARKET 146

  • 8.3 MAGNETIC RESONANCE IMAGING (MRI) 148

    • 8.3.1 EXPANDING MRI ENTERPRISE IT TO MEET RISING NEUROLOGICAL IMAGING DEMANDS TO SUPPORT MARKET GROWTH 148

  • 8.4 COMPUTED TOMOGRAPHY (CT) 149

    • 8.4.1 REGULATORY AND VALUE-BASED INCENTIVES TO FUEL CT IMAGING IT ADOPTION 149

  • 8.5 ULTRASOUND 150

    • 8.5.1 AI-POWERED ULTRASOUND AND POCUS TO ACCELERATE ENTERPRISE IMAGING TRANSFORMATION 150

  • 8.6 NUCLEAR IMAGING 151

    • 8.6.1 POSITRON EMISSION TOMOGRAPHY (PET) 153

      • 8.6.1.1 Rising PET scan volumes to drive demand for scalable, intelligent Imaging IT 153

    • 8.6.2 SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) 154

      • 8.6.2.1 Driving diagnostic accuracy with automated SPECT workflows to contribute to growth 154

  • 8.7 ENDOSCOPY 155

    • 8.7.1 ENABLING REAL-TIME ENDOSCOPIC INSIGHTS THROUGH CLOUD-NATIVE VIDEO ORCHESTRATION TO DRIVE MARKET 155

  • 8.8 MAMMOGRAPHY 156

    • 8.8.1 NEED FOR ENTERPRISE IMAGING SOLUTIONS FOR HIGH-VOLUME, HIGH-RESOLUTION MAMMOGRAPHY WORKFLOWS TO FUEL GROWTH 156

  • 8.9 FLUOROSCOPY 157

    • 8.9.1 STRATEGIC CLOUD-NATIVE IMAGING FOR ADVANCED FLUOROSCOPY USE CASES TO AID WITH GROWTH 157

  • 8.10 ECHOCARDIOGRAPHY 158

    • 8.10.1 ABILITY TO ENHANCE FLUOROSCOPY IMAGING EFFICIENCY WITH AI-INTEGRATED ENTERPRISE IT SOLUTIONS TO BOOST MARKET 158

  • 8.11 OTHER MODALITIES 159

• 9 ENTERPRISE IMAGING IT MARKET, BY OFFERING 161

  • 9.1 INTRODUCTION 162

  • 9.2 SOFTWARE 162

    • 9.2.1 ADVANCING UNIFIED IMAGING ECOSYSTEMS THROUGH CLOUD-NATIVE SOFTWARE TO BOOST MARKET GROWTH 162

  • 9.3 SERVICES 163

    • 9.3.1 ADVANTAGES SUCH AS EXPERT SERVICES, CLOUD MIGRATION, AND WORKFLOW OPTIMIZATION TO SUPPORT MARKET GROWTH 163

• 10 ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE 165

  • 10.1 INTRODUCTION 166

  • 10.2 ON-PREMISE SOLUTIONS 166

    • 10.2.1 GROWING NEED FOR IMAGING PERFORMANCE AND DATA CONTROL THROUGH ON-PREMISE DEPLOYMENT TO SUPPORT MARKET GROWTH 166

  • 10.3 CLOUD-BASED SOLUTIONS 167

    • 10.3.1 RISING NEED FOR COST-EFFICIENT, SCALABLE INFRASTRUCTURE TO DRIVE DEMAND FOR CLOUD-BASED DEPLOYMENT 167

  • 10.4 HYBRID SOLUTIONS 168

    • 10.4.1 ABILITY TO BRIDGE DATA CONTROL AND CLOUD INNOVATION THROUGH HYBRID DEPLOYMENT TO BOOST GROWTH 168

• 11 ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA 170

  • 11.1 INTRODUCTION 171

  • 11.2 NEUROLOGY 171

    • 11.2.1 INTEGRATION OF AI-DRIVEN MULTIMODAL NEUROIMAGING FOR PERSONALIZED NEUROLOGICAL CARE TO BOOST MARKET 171

  • 11.3 CARDIOLOGY 173

    • 11.3.1 CLOUD-ENABLED, AI-DRIVEN ENTERPRISE IMAGING PLATFORMS TO ACCELERATE ADVANCED CARDIAC DIAGNOSTICS 173

  • 11.4 ONCOLOGY 174

    • 11.4.1 AI-DRIVEN, MULTIMODAL ENTERPRISE IMAGING PLATFORMS TO ADVANCE PRECISION ONCOLOGY 174

  • 11.5 ORTHOPEDICS 175

    • 11.5.1 ABILITY OF AI-ENABLED ENTERPRISE IMAGING PLATFORMS TO TRANSFORM ORTHOPEDIC CARE TO DRIVE DEMAND 175

  • 11.6 OTHER THERAPEUTIC AREAS 176

• 12 ENTERPRISE IMAGING IT MARKET, BY END USER 177

  • 12.1 INTRODUCTION 178

  • 12.2 HOSPITALS 178

    • 12.2.1 HOSPITALS TO DRIVE DEMAND FOR UNIFIED IMAGING INFRASTRUCTURE TO SUPPORT INTEGRATED CARE DELIVERY 178

  • 12.3 DIAGNOSTIC CENTERS 180

    • 12.3.1 GROWING ADOPTION OF ENTERPRISE IMAGING IT TO ENHANCE WORKFLOW EFFICIENCY IN DIAGNOSTIC CENTERS TO BOOST MARKET 180

  • 12.4 CLINICS & OUTPATIENT SETTINGS 181

    • 12.4.1 GROWING POPULARITY OF LIGHTWEIGHT ENTERPRISE IMAGING IT TO BOOST EFFICIENCY AND PATIENT THROUGHPUT TO FUEL GROWTH 181

  • 12.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 182

    • 12.5.1 GROWING USE OF ENTERPRISE IMAGING IT FOR TRANSLATIONAL RESEARCH AND DRUG DEVELOPMENT TO DRIVE MARKET 182

  • 12.6 MEDTECH COMPANIES 183

    • 12.6.1 ABILITY OF ENTERPRISE IMAGING IT TO ACCELERATE DEVICE INNOVATION AND CLINICAL INTEGRATION TO FUEL ADOPTION 183

  • 12.7 RESEARCH & ACADEMIC INSTITUTES 184

    • 12.7.1 GROWING NEED TO POWER DATA-DRIVEN DISCOVERY AND COLLABORATION TO SUPPORT MARKET GROWTH 184

  • 12.8 OTHER END USERS 185

• 13 ENTERPRISE IMAGING IT MARKET, BY REGION 187

  • 13.1 INTRODUCTION 188

  • 13.2 NORTH AMERICA 188

    • 13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 189

    • 13.2.2 US 194

      • 13.2.2.1 AI integration, cloud adoption, and regulatory push to accelerate enterprise imaging IT transformation in US 194

    • 13.2.3 CANADA 199

      • 13.2.3.1 Provincial interoperability mandates and cloud-enabled AI to drive growth in Canada's imaging IT market 199

  • 13.3 EUROPE 203

    • 13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 203

    • 13.3.2 GERMANY 208

      • 13.3.2.1 Hospital modernization and ePA adoption to propel Germany’s enterprise imaging IT growth 208

    • 13.3.3 UK 212

      • 13.3.3.1 NHS push for AI-driven imaging and cloud integration to fuel market growth 212

    • 13.3.4 FRANCE 216

      • 13.3.4.1 France to accelerate cloud-native, interoperable imaging platforms with focus on data sovereignty 216

    • 13.3.5 ITALY 220

      • 13.3.5.1 Growing VNA and teleradiology adoption in Italy to modernize imaging infrastructure 220

    • 13.3.6 SPAIN 224

      • 13.3.6.1 Spain to scale cloud imaging and VNA for regional collaboration 224

    • 13.3.7 REST OF EUROPE 228

  • 13.4 ASIA PACIFIC 232

    • 13.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 233

    • 13.4.2 CHINA 239

      • 13.4.2.1 AI diagnostic approvals to accelerate market growth 239

    • 13.4.3 JAPAN 243

      • 13.4.3.1 Aging demographics to drive demand for scalable imaging solutions 243

    • 13.4.4 INDIA 247

      • 13.4.4.1 Government-led digitization to fuel imaging infrastructure expansion 247

    • 13.4.5 REST OF ASIA PACIFIC 251

  • 13.5 LATIN AMERICA 255

    • 13.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 255

    • 13.5.2 BRAZIL 260

      • 13.5.2.1 Government investments to accelerate public health digitization drives 260

    • 13.5.3 MEXICO 264

      • 13.5.3.1 Accelerating imaging modernization through nationwide digital integration in Mexico to boost market 264

    • 13.5.4 REST OF LATIN AMERICA 268

  • 13.6 MIDDLE EAST & AFRICA 272

    • 13.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 272

    • 13.6.2 GCC COUNTRIES 277

      • 13.6.2.1 Enterprise imaging adoption accelerates across GCC amid workforce gaps and digital health push to support growth 277

    • 13.6.3 REST OF MIDDLE EAST & AFRICA 282

• 14 COMPETITIVE LANDSCAPE 286

  • 14.1 OVERVIEW 286

  • 14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 286

    • 14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ENTERPRISE IMAGING IT MARKET 287

  • 14.3 REVENUE ANALYSIS, 2020-2024 290

  • 14.4 MARKET SHARE ANALYSIS, 2024 291

  • 14.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 293

    • 14.5.1 STARS 293

    • 14.5.2 EMERGING LEADERS 293

    • 14.5.3 PERVASIVE PLAYERS 293

    • 14.5.4 PARTICIPANTS 294

    • 14.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 295

      • 14.5.5.1 Company footprint 295
      • 14.5.5.2 Region footprint 296
      • 14.5.5.3 Function footprint 297
      • 14.5.5.4 Application footprint 298
      • 14.5.5.5 Therapeutic area footprint 299
      • 14.5.5.6 Deployment mode footprint 300

  • 14.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 301

    • 14.6.1 PROGRESSIVE COMPANIES 301

    • 14.6.2 RESPONSIVE COMPANIES 301

    • 14.6.3 DYNAMIC COMPANIES 301

    • 14.6.4 STARTING BLOCKS 301

    • 14.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 303

      • 14.6.5.1 Detailed list of key startups/SMEs 303
      • 14.6.5.2 Competitive benchmarking of startups/SMEs 303

  • 14.7 COMPANY VALUATION & FINANCIAL METRICS 305

    • 14.7.1 FINANCIAL METRICS 305

    • 14.7.2 COMPANY VALUATION 305

  • 14.8 BRAND/SOFTWARE COMPARISON 306

  • 14.9 COMPETITIVE SCENARIO 307

    • 14.9.1 SOLUTION LAUNCHES, APPROVALS, AND ENHANCEMENTS 307

    • 14.9.2 DEALS 308

    • 14.9.3 EXPANSIONS 309

• 15 COMPANY PROFILES 310

  • 15.1 KEY PLAYERS 310

    • 15.1.1 AGFA-GEVAERT GROUP 310

      • 15.1.1.1 Business overview 310
      • 15.1.1.2 Solutions offered 311
      • 15.1.1.3 Recent developments 313
        • 15.1.1.3.1 Deals 313
      • 15.1.1.4 MnM view 314
        • 15.1.1.4.1 Key strengths 314
        • 15.1.1.4.2 Strategic choices 314
        • 15.1.1.4.3 Weaknesses & competitive threats 314

    • 15.1.2 FUJIFILM HOLDINGS CORPORATION 315

      • 15.1.2.1 Business overview 315
      • 15.1.2.2 Solutions offered 317
      • 15.1.2.3 Recent developments 318
        • 15.1.2.3.1 Deals 318
      • 15.1.2.4 MnM view 318
        • 15.1.2.4.1 Key strengths 318
        • 15.1.2.4.2 Strategic choices 319
        • 15.1.2.4.3 Weaknesses & competitive threats 319

    • 15.1.3 GE HEALTHCARE 320

      • 15.1.3.1 Business overview 320
      • 15.1.3.2 Solutions offered 321
      • 15.1.3.3 Recent developments 322
        • 15.1.3.3.1 Solution launches & approvals 322
        • 15.1.3.3.2 Deals 323
      • 15.1.3.4 MnM view 324
        • 15.1.3.4.1 Key strengths 324
        • 15.1.3.4.2 Strategic choices 324
        • 15.1.3.4.3 Weaknesses & competitive threats 324

    • 15.1.4 KONINKLIJKE PHILIPS N.V 325

      • 15.1.4.1 Business overview 325
      • 15.1.4.2 Solutions offered 326
      • 15.1.4.3 Recent developments 328
        • 15.1.4.3.1 Solution launches & approvals 328
        • 15.1.4.3.2 Deals 329
        • 15.1.4.3.3 Expansions 329
      • 15.1.4.4 MnM view 330
        • 15.1.4.4.1 Key strengths 330
        • 15.1.4.4.2 Strategic choices 330
        • 15.1.4.4.3 Weaknesses & competitive threats 330

    • 15.1.5 SIEMENS HEALTHINEERS AG 331

      • 15.1.5.1 Business overview 331
      • 15.1.5.2 Solutions offered 332
      • 15.1.5.3 Recent developments 335
        • 15.1.5.3.1 Solution launches 335
        • 15.1.5.3.2 Deals 335
      • 15.1.5.4 MnM view 335
        • 15.1.5.4.1 Key strengths 335
        • 15.1.5.4.2 Strategic choices 336
        • 15.1.5.4.3 Weaknesses & competitive threats 336

    • 15.1.6 OPTUM, INC 337

      • 15.1.6.1 Business overview 337
      • 15.1.6.2 Solutions offered 338
      • 15.1.6.3 Recent developments 340
        • 15.1.6.3.1 Deals 340
      • 15.1.6.4 MnM view 340
        • 15.1.6.4.1 Key strengths 340
        • 15.1.6.4.2 Strategic choices 340
        • 15.1.6.4.3 Weaknesses & competitive threats 341

    • 15.1.7 SECTRA AB 342

      • 15.1.7.1 Business overview 342
      • 15.1.7.2 Solutions offered 344
      • 15.1.7.3 Recent developments 346
        • 15.1.7.3.1 Solution launches & approvals 346
        • 15.1.7.3.2 Deals 347

    • 15.1.8 CANON MEDICAL SYSTEMS CORPORATION 348

      • 15.1.8.1 Business overview 348
      • 15.1.8.2 Solutions offered 350
      • 15.1.8.3 Recent developments 351
        • 15.1.8.3.1 Deals 351
        • 15.1.8.3.2 Expansions 351

    • 15.1.9 MERATIVE 352

      • 15.1.9.1 Business overview 352
      • 15.1.9.2 Solutions offered 352
      • 15.1.9.3 Recent developments 353
        • 15.1.9.3.1 Deals 353
        • 15.1.9.3.2 Expansions 353

    • 15.1.10 PRO MEDICUS, LTD 354

      • 15.1.10.1 Business overview 354
      • 15.1.10.2 Solutions offered 356
      • 15.1.10.3 Recent developments 357
        • 15.1.10.3.1 Solution launches 357
        • 15.1.10.3.2 Deals 357

    • 15.1.11 INTELERAD MEDICAL SYSTEMS INCORPORATED 358

      • 15.1.11.1 Business overview 358
      • 15.1.11.2 Solutions offered 358
      • 15.1.11.3 Recent developments 360
        • 15.1.11.3.1 Solution launches 360
        • 15.1.11.3.2 Deals 360

    • 15.1.12 HYLAND SOFTWARE, INC 362

      • 15.1.12.1 Business overview 362
      • 15.1.12.2 Solutions offered 362
      • 15.1.12.3 Recent developments 363
        • 15.1.12.3.1 Solution launches 363
        • 15.1.12.3.2 Deals 363

    • 15.1.13 INFINITT HEALTHCARE CO., LTD 365

      • 15.1.13.1 Business overview 365
      • 15.1.13.2 Solutions offered 366
      • 15.1.13.3 Recent developments 366
        • 15.1.13.3.1 Solution launches & approvals 366
        • 15.1.13.3.2 Deals 367

    • 15.1.14 NOVARAD 368

      • 15.1.14.1 Business overview 368
      • 15.1.14.2 Solutions offered 368

    • 15.1.15 MACH7 TECHNOLOGIES 370

      • 15.1.15.1 Business overview 370
      • 15.1.15.2 Solutions offered 372
      • 15.1.15.3 Recent developments 373
        • 15.1.15.3.1 Solution launches 373
        • 15.1.15.3.2 Deals 373

    • 15.1.16 HERMES MEDICAL SOLUTIONS 374

      • 15.1.16.1 Business overview 374
      • 15.1.16.2 Solutions offered 374
      • 15.1.16.3 Recent developments 376
        • 15.1.16.3.1 Solution launches, approvals, and enhancements 376
        • 15.1.16.3.2 Deals 377

    • 15.1.17 KONICA MINOLTA, INC 378

      • 15.1.17.1 Business overview 378
      • 15.1.17.2 Solutions offered 379
      • 15.1.17.3 Recent developments 381
        • 15.1.17.3.1 Solution launches & enhancements 381
        • 15.1.17.3.2 Deals 381

    • 15.1.18 BRIDGEHEAD SOFTWARE LTD 383

      • 15.1.18.1 Business overview 383
      • 15.1.18.2 Solutions offered 383
      • 15.1.18.3 Recent developments 384
        • 15.1.18.3.1 Deals 384

    • 15.1.19 SCIMAGE, INC 385

      • 15.1.19.1 Business overview 385
      • 15.1.19.2 Solutions offered 385
      • 15.1.19.3 Recent developments 386
        • 15.1.19.3.1 Solution launches 386
        • 15.1.19.3.2 Deals 387

    • 15.1.20 VISUS HEALTH IT GMBH 388

      • 15.1.20.1 Business overview 388
      • 15.1.20.2 Solutions offered 388
      • 15.1.20.3 Recent developments 389
        • 15.1.20.3.1 Solution enhancements 389

  • 15.2 OTHER PLAYERS 390

    • 15.2.1 DICOM SYSTEMS, INC 390

    • 15.2.2 POSTDICOM 391

    • 15.2.3 QAELUM 392

    • 15.2.4 ADVAHEALTH SOLUTIONS 393

    • 15.2.5 PAXERAHEALTH 394

    • 15.2.6 RAD AI 395

• 16 APPENDIX 396

  • 16.1 DISCUSSION GUIDE 396

  • 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 402

  • 16.3 CUSTOMIZATION OPTIONS 404

  • 16.4 RELATED REPORTS 405

  • 16.5 AUTHOR DETAILS 406